T lymphocyte-targeted immunofusion protein

Drug Profile

T lymphocyte-targeted immunofusion protein

Alternative Names: Genimmune; Genimune; TIF

Latest Information Update: 14 Oct 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator XOMA
  • Class
  • Mechanism of Action Immunosuppressants; T lymphocyte inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Autoimmune disorders; Leukaemia

Most Recent Events

  • 14 Oct 2008 Discontinued - Preclinical for Autoimmune disorders in USA (IV-infusion)
  • 14 Oct 2008 Discontinued - Preclinical for Leukaemia in USA (IV-infusion)
  • 12 Mar 2002 Suspended - Preclinical for Autoimmune disorders in USA (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top